Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion type Assertion NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_head.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion description "[Granulin-epithelin precursor (GEP) has previously been reported to control cancer growth, invasion, chemo-resistance, and served as novel therapeutic target for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_provenance.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion evidence source_evidence_literature NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_provenance.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion SIO_000772 22792281 NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_provenance.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion wasDerivedFrom befree-20150227 NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_provenance.
- NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_assertion wasGeneratedBy ECO_0000203 NP434223.RAeLaHyxZeDVFh4Zkx37uYYIY0jqZfIoJf9Wyj3f8pdvU130_provenance.